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Abstract
Introduction: Brown tumors are a rare focal manifestation of osteitis fibrosa cystica, which results
from hyperparathyroidism. Chronic kidney failure may lead to secondary or tertiary hyperpara-
thyroidism and thus to osteitis fibrosa cystica and brown tumors.
Case presentation: A 60-year-old man with a history of diabetes mellitus and chronic kidney
failure presented with a 15-day history of dyspnea, cough, malaise and fever. Initially, there was little
correlation between his history and his physical examination. Various pulmonary, cardiac and
infectious etiologies were ruled out. A chest X-ray showed a costal mass that was further verified by
tomography and gammagraphy. The mass was suspected of being neoplastic. After a failed biopsy, the
mass was removed surgically and on histopathology was compatible with a giant-cell tumor versus a
brown tumor caused by hyperparathyroidism. Laboratory tests showed elevated calcium, phosphate
and parathyroid hormone concentrations. The patient was diagnosed with a brown tumor secondary
to refractory hyperparathyroidism.
Conclusion: Tending towards a diagnosis because it is more frequent or it implies more risk for the
patient may delay the consideration of other diagnostic options that, although rare, fit well into the
clinical context. The patient presented here was suspected to have an osseous neoplasia that would
have had major implications for the patient. However, reassessment of the case led to the diagnosis of
a brown tumor. Brown tumors should be an important diagnostic consideration in patients with
chronic kidney failure who have secondary or tertiary hyperparathyroidism and an osseous mass.
Introduction
The first case in the literature reporting a brown tumor was
publishedin1953 anddescribedafronto-ethmoidalbrown
tumor [1]. However, previous reports of patients with
localized forms of osteitis fibrosa cystica (OFC) suggest
that the clinical entity was described earlier, at a time when
there were few treatment options for chronic kidney failure
(CKF) and consequently chronic hyperparathyroidism was
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represent a focal manifestation of OFC resulting from
hyperparathyroid states. Patients suffering from CKF may
develop secondary or tertiary hyperparathyroidism due to
altered phosphorus and calcium metabolism. Persistent
hyperparathyroidism leads to altered osseous metabolism
with bone resorption and tissue changes collectively known
as OFC. Our case report describes a patient with poorly
controlled CKF who presented with a non-specific clinical
pictureandnocleardiagnosis.Incidentallyacostalmasswas
found and the diagnostic workup that followed led to an
unexpected diagnosis.
Case presentation
A 60-year-old man was transferred from the hemodialysis
unit to the emergency room because of a 15-day history of
malaise, subjective fever, shortness of breath, dry cough,
abdominal pain and diarrhea. He also complained of mild
anterior thoracic pain not associated with other symptoms
and which was not irradiated. He had a 20-year history of
type 2 diabetes mellitus (DM) that required insulin, with
micro- and macro-vascular complications such as diabetic
retinopathy and CKF. He was on hemodialysis and had a
history of multiple failed dialysis accesses. He also suffered
from arterial hypertension, upper and lower extremity
peripheralarterialdisease,carotidarterydisease,afirstdegree
atrioventricular heart block and had smoked one packet of
cigarettes per day for the last 20 years. He was being treated
with sevelamer, erythropoietin, folic acid, lovastatin, gemfi-
brozil, NPH insulin, amlodipine and acetylsalicylicacid, but
was not receiving calcium or a vitamin D supplement.
A physical examination revealed the patient to be in a fair
condition, with no apparent distress, hydrated, alert and
well oriented. He had a heart rate of 92 beats per minute,
respiratory rate of 14 breaths per minute, blood oxygen
saturationof97%,arterialbloodpressureof130/70 mmHg
a n dn of e v e r .H eh a db i l a t e r a lb l i n d n e s sa n dm i l de p i s t a x i s
throughtheleftnostril.Thethoraxwastendertopalpationin
some costochondral unions, but pain was poorly localized.
The vesicular murmur had reduced intensity and no
pathologic sounds were auscultated. Peripheral pulses were
weak in both the upper and the lower limbs. He had a
translumbar hemodialysis catheter. The remaining physical
examination was unremarkable.
The patient had stable vital signs and had no signs of
systemic inflammatory response. However, because of the
patient's previous history of DM, CKF and the presence of
leukocytosis, neutrophilia and elevated C-reactive protein
upon admission (Table 1), we initially ruled out a
gastrointestinal or lung infection, or any cardiac cause
for the patient's symptoms. The electrocardiogram showed
no signs of ischemia, and the chest X-ray showed
cardiomegaly, a small left pleural effusion, a circular
opacity in the right inferior thoracic region and no signs of
consolidation. These findings were initially interpreted as
a pulmonary infection, probably a lung abscess, an
abscedated nodule or pulmonary tuberculosis. A contrast
tomography scan of the chest was ordered for further
characterization. Though it showed no parenchymal
compromise, a 4 × 1.3 cm lesion was observed on the
right dorsal region of the eighth rib. The lesion showed
thinning of cortical bone in some areas, preserved cortex
and lacked periosteal reaction (Figure 1). The radiology
staff considered a bone metastasis as a first diagnostic
option, and a thoraco-abdomino-pelvic tomography scan
was done in search for more lesions and a probable
primary tumor. Additional hypodense lesions were
observed, including one on the left lamina of L4,
acetabulum, and head and neck of the right femur. There
was no lymph-node or internal organ compromise. A Tc
Table 1. Laboratory results upon admission and throughout hospital stay
Laboratory exams (reference range) Day 1 Day 2 Day 7 Day 9 Day 18 Day 20







Neutrophils (40-70%) 82 70
Lymphocytes (22-44%) 2 14
CRP (0.08-3.1 mg/liter) 12.20
Creatinine (<1.5 mg/dl) 6.5
BUN (10-20 mg/dl) 43
Sodium (136-145 mg/dl) 137 140 139
Potassium (3.5-5 mg/dl) 5.0 7.4 5.9
Calcium (9-10.5 mg/dl) 11.2 9.5 9.1 9.2
Phosphorus (3-4.5 mg/dl) 5.3
Alkaline phosphatase (30-120 U/liter) 139
Troponin
* (0-0.4 ng/ml) 1.83 1.19
Fecal occult blood Negative
PSA (0-4 ng/ml) 0.748
CEA 0-3.4 (μg/liter) 3.6
* Chronic renal failure may elevate troponin levels independently from myocardial damage.
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hypermetabolic focus compatible with a neoplastic lesion,
concordant in size and location with the costal mass
reported in the previous imaging studies. It also revealed
generalized osseous compromise compatible with renal
osteodystrophy and did not confirm the other lesions
described on tomography. A tomography-guided biopsy
specimen (Figure 1) was obtained, but histopathological
analysis reported normal tissue components.
Not being able to reach a clear diagnosis, a careful
r e a s s e s s m e n to ft h ep a t i e n t ’s clinical record led to
considering the alternative diagnosis of renal osteodystro-
phy. This was supported by a history of poorly controlled
CKF, elevated calcium (11.2 mg/dl) and phosphorus
(5.3 mg/dl) concentrations, a phosphocalcic product of
59.36 mg
2/dl
2, and a bone gammagraphy that showed
changes compatible with OFC. However, the possibility of
neoplasia was still being considered so the mass was
removed surgically. Histopathological studies reported an
osseous tissue with spindles of fusiform cells in a storiform
disposition with abundant multinucleated giant cells,
some macrophages and some mononuclear cells. Scarce
mitotic activity was observed, and there were no signs of
malignancy (Figure 2). The pathologist concluded that the
findings were compatible with a giant-cell tumor or a
brown tumor, both histologically very similar [2]. Para-
thyroid hormone (PTH) concentration was 1377 pg/ml.
These findings were compatible with refractory hyperpar-
athyroidism, and a diagnosis of a brown tumor of
hyperparathyroidism associated with CKF was reached.
The patient continued ambulatory medical treatment with
vitamin D, calcium and sevelamer. Two months after
discharge, the parathyroid level was 1900 pg/ml and a Tc
99 m Sestamibi scan revealed hyperfunctioning glands
despite aggressive pharmacological treatment. Serum
calcium and phosphorus levels were within normal limits,
9.4 mg/dl and 3.4 mg/dl, respectively. At the time of
writing, the patient was awaiting parathyroidectomy as
definite treatment for tertiary hyperparathyroidism asso-
ciated with severe renal osteodystrophy.
Discussion
Brown tumors are unusual bone lesions that represent a
localized manifestation of OFC induced by hyperpara-
thyroidism, independent of its cause. Increased PTH levels
and locally produced tumour necrosis factor a and
interleukin 1 (IL-1) by marrow monocytes induce the
proliferation and differentiation of pluripotent bone-
marrow cells into osteoblasts. These cells produce granu-
locyte macrophage colony stimulating factor, IL-6, IL-11
and stem-cell factor that induce the migration and
differentiation of monocytes into osteoclasts, increasing
the number of the latter in the bone tissue. Enhanced
activity of osteoclasts and osteoblasts leads to bone
resorption and a reduction of bone mineral concentration
with an increased proliferation of fibrous tissue and
extracellular matrix [3]. Brown tumors develop in 3% to
4% of patients with primary hyperparathyroidism and in
1.5% to 1.7% of patients with secondary causes of
hyperparathyroidism [4]. However, around half of
patients with CKF may develop OFC due to secondary
hyperparathyroidism making brown tumors more fre-
quent in these patients. Brown tumors have been reported
in patients with primary hyperparathyroidism due to
Figure 1. Tomographicimageduringguidedbiopsyprocedure.
Note the heterogeneous 4 × 1.3 cm mass (arrow), with
preserved cortical bone and no periosteal reaction or other
inflammatory signs. No cysts were identified.
Figure 2. Microscopic pathology of surgical specimen.
Presence of various multinucleated giant cells (arrows) and
spindle arranged cells. Hemosiderin deposits were not
observed in the sample. Hematoxylin-eosin stain at
40 × magnification.
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gland; vitamin D deficiency due to lack of sunlight ex-
posure [7] or due to intestinal malabsorption syndromes
[8]; and secondary [9] or tertiary hyperthyroidism [10] in
patients suffering CKF. Hyperphosphatemia with hypo-
calcemia caused by tubular damage and impaired
vitamin D metabolism explains hyperparathyroidism in
these patients.
Brown tumors are either mono- or polyostotic benign
masses, painless and usually found incidentally. However,
they may cause tissue damage to adjacent structures and
compressive manifestations such as pain, neuropathies
[11] and myelopathy [12]. The majority of cases report the
maxilla and mandible as the main sites of occurrence [9].
Other common sites are the clavicles, scapula, pelvis and
ribs; however, these lesions may appear in any osseous
structure [7], including chondral tissue [13]. They are
associated with an increased risk of fractures if localized in
weight-bearing areas [14].
Brown tumors arise from foci of OFC and represent a
reparative bone process rather than true neoplastic
lesions, as there is no hyperplasia or clonal cell pro-
liferation. Typical histopathology describes spindle cells
or fibroblasts in areas of osseous lysis, multinucleated
giant cells (probably osteoclasts), increased vasculariza-
tion and accumulation of hemosiderin-laden macro-
phages, with micro-hemorrhages which confer a
brownish appearance to the affected tissue. Cysts and
areas of necrosis may be found [2,5]. Brown tumors are
histologically similar to giant-cell tumors, giant-cell
regenerative granulomas, cherubism and aneurismatic
osseous cysts [2,4].
On X-ray imaging, brown tumors appear as lytic lesions
with thinned cortical bone that may be fractured.
Concurrent changes that suggest OFC such as osteope-
nia, a “salt-and-pepper” bone appearance, subperiosteal
bone resorption and disappearance of the lamina dura
around the roots of the teeth, may help differentiate it
from other entities [4]. Tomographic imaging shows an
osseous mass, with no cortical disruption, no periosteal
reaction or inflammatory signs, a heterogeneous center
and areas that suggest cysts [14]. Magnetic resonance
imaging (MRI) shows variable intensities on T2-
weighted images and intense enhancement on T1-
weighted contrast MRI. MRI may be better for determin-
ing the presence of cysts or fluid filled levels; a finding
that is very suggestive of a brown tumor [14]. Osseous
gammagraphy is not indicated for the diagnosis of
brown tumors; however, isolated hypermetabolic lesions
or simultaneous hypercaptation of bone lesions and
parathyroid adenomas, when done with Tc 99 m Sesta-
mibi, have been described [15].
Although differential diagnoses for an isolated bone lesion
are extensive, when confronted with a patient with CKF, an
osseous mass and laboratory data that show increased
levels of calcium, phosphate, phosphocalcic product as
well as alkaline phosphatase, it is imperative to determine
PTH levels to rule out hyperparathyroidism. Histopatho-
logical analysis of the osseous lesion is needed to confirm
the diagnosis of a brown tumor. In the case presented here,
parathyroidlevelswerenotassessedearlierbecauseanother
diagnosis, osseous neoplasia, was suspected which posed
major prognostic value and risk for the patient. A
parathyroid hormone measurement six months earlier
reported 570 pg/ml; thus, it is probable that the patholo-
gical process evolved during this brief time.
Treatment of brown tumors relies on a definitive control
of the underlying hyperparathyroid state. In a patient with
CKF, this is achieved through the administration of
phosphorus chelators, and calcium and vitamin D sup-
plementation. In patients presenting with tertiary hyper-
parathyroidism, parathyroidectomy may be required.
Osseous lesions usually cease to grow, then shrink and
eventually ossify without further consequences for the
patient. Surgery is required under certain circumstances,
such as: 1) compressive neurologic symptoms over
peripheral nerves, cauda equina or spinal medulla; 2) a
significant anatomical deformity; 3) risk of a pathologic
fracture; 4) when the symptoms or pain do not resolve
despite adequate medical treatment and control of the
hyperparathyroid state; and 5) when the biopsy does not
yield a clear diagnosis, as with the present case [9,11,12].
Conclusion
The case presented here illustrates how brown tumors,
though rare, should be considered in patients with CKF
and an osseous mass. The initial clinical presentation of
this patient, a history of DM with a non-compensated CKF
and the laboratory studies suggested an infectious process.
Retrospectively, these initial complaints and findings
could be explained by the patient’s renal condition with
volume overload, severe anemia, hydro-electrolyte distur-
bances, as well as altered calcium and phosphate metabo-
lism. Early diagnosis and proper management of CKF
enable an optimal control of bone-mineral metabolism,
thus decreasing the incidence of OFC and making brown
tumors rare lesions. Nevertheless, when confronted with a
patient with CKF and an osseous mass, a brown tumor
caused by hyperparathyroidism should always be consid-
ered in the differential diagnosis.
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